Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice
暂无分享,去创建一个
W. Vainchenker | S. Eddahibi | E. Marcos | S. Adnot | O. Wagner-Ballon | A. Hulin | B. Maître | W. Raoul | S. Giraudier | Guitanouch Saber
[1] D. Stewart,et al. Microvascular Regeneration in Established Pulmonary Hypertension by Angiogenic Gene Transfer Materials and Methods Cell Isolation and Culture , 2022 .
[2] V. Peinado,et al. Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory cell and molecular biology.
[3] D. Link,et al. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. , 2005, Blood.
[4] T. Skalak,et al. Mobilization of Bone Marrow–Derived Cells Enhances the Angiogenic Response to Hypoxia Without Transdifferentiation Into Endothelial Cells , 2005, Circulation research.
[5] R. Poulsom,et al. Repopulation of human pulmonary epithelium by bone marrow cells: a potential means to promote repair. , 2005, Tissue engineering.
[6] R. Mulligan,et al. Failure of bone marrow to reconstitute lung epithelium. , 2005, American journal of respiratory cell and molecular biology.
[7] D. Stewart,et al. Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease , 2005, Circulation research.
[8] C. Corless,et al. Transplanted human bone marrow contributes to vascular endothelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[10] M. Frid,et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. , 2004, American journal of physiology. Lung cellular and molecular physiology.
[11] W. Seeger,et al. Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth , 2003, Circulation research.
[12] M. Varella‐Garcia,et al. Human pulmonary chimerism after hematopoietic stem cell transplantation. , 2003, American journal of respiratory and critical care medicine.
[13] Naftali Kaminski,et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Opolon,et al. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice. , 2003, American journal of respiratory cell and molecular biology.
[15] Y. Tabata,et al. Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells , 2003, Circulation.
[16] U. Lehmann,et al. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR‐analysis , 2002, Hepatology.
[17] D. Kotton,et al. Bone marrow-derived cells as progenitors of lung alveolar epithelium. , 2001, Development.
[18] D. Stewart,et al. Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension , 2001, Circulation.
[19] Neil D. Theise,et al. Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.
[20] Peter Goodfellow,et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes , 1990, Nature.
[21] D. Link,et al. AMD 3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism , 2006 .
[22] S. Ogawa,et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. , 2005, Chest.
[23] I. Weissman,et al. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. , 1997, Blood.
[24] J. Brown,et al. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. , 1989, Toxicon : official journal of the International Society on Toxinology.